Check Emergent Biosolutions Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$415.6M
EPS (TTM)
1.19
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
6.00%
PE Ratio (TTM)
2.97
Industry PE ratio
-3.9415151515151514
P/B Ratio
2.9733
PEG Ratio
1.55
EBITDA
216.8M
Revenue (TTM)
851.6M
Profit Margin
16.38%
Return On Equity TTM
30.24%
Track how Emergent Biosolutions Inc P/E has moved over time to understand its valuation trends.
Emergent Biosolutions Inc in the last 5 years
Lowest (3.44x)
June 30, 2025
Industry (-3.94x)
September 18, 2025
Today (2.97x)
September 18, 2025
Highest (18.75x)
September 30, 2020
Today’s Price to Earnings Ratio: 2.97x
Compare market cap, revenue, PE, and other key metrics of Emergent Biosolutions Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$415.6M | -92.26% | 2.97 | 16.38% | ||
BUY | $18.3B | NA | 15.75 | 40.36% | |
BUY | $42.0B | NA | 20.89 | 13.81% | |
BUY | $14.2B | 40.41% | 42.23 | 13.88% | |
BUY | $65.1B | -8.67% | 25.29 | 27.83% |
The Emergent Biosolutions Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Emergent Biosolutions Inc investment value today
Current value as on today
₹1,19,156
Returns
₹19,156
(+19.16%)
Returns from Emergent Biosolutions Inc Stock
₹14,203 (+14.2%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 9 analysts
11.11%
Buy
22.22%
Hold
66.67%
Sell
Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Emergent Biosolutions Inc. Average target price of $13.5
Get share price movements and forecasts by analysts on Emergent Biosolutions Inc.
What analysts predicted
41.63%UPSIDE
Target Price
$13.5
Current Price
$7.88
Analyzed by
9 Analysts
Target
$13.50
Emergent Biosolutions Inc target price $13.5, a slight upside of 41.63% compared to current price of $7.88. According to 9 analysts rating.
Search interest for Emergent Biosolutions Inc Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 09 September
Tue, 05:00 PM
-Emergent BioSolutions announces $56 million contract modification to supply ACAM2000 vaccine to the U.S. government, boosting total projected sales.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, United Therapeutics Corporation has given 34.5% return, outperforming this stock by 100.6%
Against Peers
In the last 1 year, Neurocrine Biosciences Inc. has given 19.1% return, outperforming this stock by 6.2%
Price Dip
In the last 1 month, EBS stock has moved down by -14.1%
Revenue Fall
Revenue is down for the last 2 quarters, 222.2M → 140.9M (in $), with an average decrease of 36.6% per quarter
Profit Down
Netprofit is down for the last 2 quarters, 68.0M → -12.0M (in $), with an average decrease of 117.7% per quarter
Organisation | Emergent Biosolutions Inc |
Headquarters | 300 Professional Drive, Gaithersburg, MD, United States, 20879 |
Industry | Health Technology |
CEO | Mr. Joseph C. Papa Jr., M.B.A., R.Ph. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Jessica Perl | Senior VP, Corporate Secretary & General Counsel |
Ms. Michelle Pepin | Senior VP & Chief Human Resource Officer |
Mr. Simon C. Lowry M.D. | Chief Medical Officer and Head of Research & Development |
Mr. Joseph C. Papa Jr., M.B.A., R.Ph. | CEO, President & Director |
Mr. Richard S. Lindahl M.B.A. | Executive VP, CFO & Treasurer |
Ms. Coleen Glessner | Executive Vice President of Quality, Ethics & Compliance |
Mr. Paul A. Williams | Senior Vice President of Products Business |
Mr. William Hartzel | Senior Vice President of Manufacturing & Bioservices |
Ms. Stephanie Duatschek | Chief Global Strategy & Franchise Development Officer |
Emergent Biosolutions Inc share price today is $7.88 as on . Emergent Biosolutions Inc share today touched a day high of $8.04 and a low of $7.88.
Emergent Biosolutions Inc share touched a 52 week high of $12.73 on and a 52 week low of $4.02 on . Emergent Biosolutions Inc stock price today i.e. is trending at $7.88,which is 38.10% down from its 52 week high and 96.02% up from its 52 week low.
Emergent Biosolutions Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Emergent Biosolutions Inc (EBS) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Emergent Biosolutions Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Emergent Biosolutions Inc share’s latest price of $7.88 as on September 18, 2025 at 8:37 pm IST, you will get 1.2690 shares of Emergent Biosolutions Inc. Learn more about
fractional shares .
Emergent Biosolutions Inc stock has given -92.26% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?